5Hardick.J, Hsieh YH.Surveillance of Chlamydia trachomatis and Neisseria gonorrhoeae infections in women in Detention in Baltimore[J]. Mayylomd Sex Transm Dis, 2003,30 : 70.
6Guaschinos.Complicatioas of sexually transmitted disease: clinical course and treatment[J]. Ann Ist Super sanita, 2000, 36: 431.
7Rempel EG, Shamanin VA. Comparison of various PCR methods for the detection Of Chlamydia trachomatis, ureaplasma urealyticum and Mycoplasma hominis in women with impaired reproductive function[J]. ZH Mikrobiol Epidemiol Immunobiol, 2000, 6: 76.
3CulleyCM,LacyMK,KlutmanN,et al.Moxifloxacin:clinical efficady and safety [J].Am J Health Syst Pharm,2001,58(5):379-388
4StassHH,DalhoffA,KubituaD,et al.Pharmacokinetics,safety and tolerability of ascending single doses of moxifloxacin,a new methoxyquinolone,administered to healthy subject [J].Antimicrob Agents Chemothet,1998,42(8):2060-2065
5BallP.Moxifloxacin (Avelox):an 8-methoxyquinolone antibacterial with enhanced potency [J].IntJ ClinParact,2000,54(5):329-332